CFOR
What one share of Capforce holds
Services – Medical Laboratories
Please refer to the Glossary at the end of this Business section for definitions or descriptions of industry, regulatory, and CapForce-specific terms used in this Annual Report.
Capforce’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $6.71 |
|---|---|
| Profit | $5.45 |
| Cash and investments | $0.01 |
| Book value | $5.99 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2020 | $53.34 | −$331.77 | $1.65 | −$297.79 | — | $168.95 |
| 2021 | $23.48 | −$228.89 | $10.82 | −$127.95 | — | $177.47 |
| 2022 | $10.68 | −$152.70 | $2.42 | −$86.18 | — | $26.12 |
| 2023 | $4.34 | −$41.47 | $1.02 | −$19.19 | — | −$9.01 |
| 2024 | $1.00 | $2.30 | — | −$0.93 | — | $0.73 |
| 2025 | $2.98 | $2.32 | $0.00 | −$0.12 | — | $3.14 |